DATE POSTED T I T L E / A N N O U N C E M E N T
October 20, 2016 Physical Activity and Cognitive Function in Adults with Multiple Sclerosis: An Integrative Review
by Janet D. Morrison & Lori Mayer

Published Online: October 20, 2016

Purpose: To identify and synthesize the research evidence concerning (1) the relationship between physical activity and cognitive performance in persons with multiple sclerosis (MS) and (2) to review the reported effects of physical activity interventions on neurocognitive performance conducted in this population. 

DATE POSTED T I T L E / A N N O U N C E M E N T
August 2013 - May 2014 WEBINAR: 2013-14 TOWN HALL DISCUSSIONS
View Presentations (PDF)

WEBINAR: 2013-14 TOWN HALL DISCUSSIONS:

Access Webinars


October 14, 2014 FDA Perpmits Marketing of Urinary Prosthesis Device for Women
Release Date: October 14, 2014

The U.S. Food and Drug Administration today allowed marketing of the inFlow Intraurethral Valve-Pump, a replaceable urinary prosthesis for use in female adults who cannot contract the muscles necessary to push urine out of the bladder (impaired detrusor contractility or IDC). 

September, 2014 Acute Neurologic Illness with Focal Limb Weakness of Unknown Etiology in Children

In September, the Centers for Disease Control and Prevention (CDC) issued a Health Advisory to healthcare professionals nationwide to be vigilant for and report cases of neurologic illnesses associated with limb weakness that meet the criteria of its case definition. 

August, 2014 PEGYLATED INTERFERON BETA-1A (PLEGRIDY) – Clinician Information

Generic: Peginterferon Beta-1a
Brand name: Plegridy
US FDA Approved: August 2014

February 4, 2014 Genzyme's Lemtrada Approved in Mexico for Treatment of MS

On February 4, 2014, Genzyme, a Sanofi company, announced that Mexico’s national regulatory authority, COFEPRIS, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing remitting forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.

January 28, 2014 New Copaxone Dosing Approved for Fewer Injections

On January 28, 2014, Teva Pharmaceutical Industries Ltd. announced that the new, three-times-per-week dosing of Copaxone® (glatiramer acetate), at the more concentrated dose of 40 mg, has been approved by the FDA.


DATE POSTED T I T L E / A N N O U N C E M E N T
May 2012 - May 2013 PODCAST: 2012-13 TOWN HALL DISCUSSIONS
View Presentations (PDF)

PODCAST: 2012-13 TOWN HALL DISCUSSIONS:

Listen to PODCAST


April 2012 Novartis Announces Update to GilenyaTM (fingolimod) U.S. Prescribing Information Following FDA Review

Novartis Press Release: click here

Gilenya Prescribing Information
(PDF: 427KB)


In addition, on April 20, 2012, the European Medicines Agency (EMA) issued a press release outlining changes to the recommended use of Gilenya in the European Union (Summary of Product Characteristics). These recommendations do not apply to the U.S.

EMA Press Release: click here

Summary of Product Characteristics
(PDF: 384KB)


March 2012 THE JANET PEARCE  MS NURSE TRAINING PROGRAM

March 23 and 24, 2012 (Friday and Saturday)
The NYU Wasserman Center for Career Development
133 East 13th St. (between 3rd and 4th Avenues), 2/F
New York, N.Y. 10003
8:30 a.m. – 4:30 p.m. (both days)

This is the eighth conference of the Janet Pearce MS Nurse Training Program which began 10 years ago. For more information contact Andrea Arzt at 212-453-3215 or aarzt@msnyc.org.

View Complete Program Information

March 2012 THE 4TH ANNUAL LINDA MORGANTE MS NURSE LEADERSHIP PROGRAM

This intensive, two-day course on contemporary topics in MS is led by faculty who are thought leaders in MS nursing. The program will be held Monday through Wednesday, May 28-30, 2012 at the Hilton San Diego Bayfront, immediately preceding the CMSC Annual Meeting in San Diego, California.

To apply for the program you must be a nurse with an interest in MS who is based in the United States or Canada. Please complete the application to apply for the program.

Space is limited to 40 nurses, apply by March 9, 2012! Please contact Katie at 877-444-8435 ext. 159 or if you have any questions.

View Complete Program Information


DATE POSTED T I T L E
Jan - Dec, 2011 PODCAST: 2011 TOWN HALL DISCUSSIONS
View Presentations (PDF)

PODCAST: 2011 TOWN HALL DISCUSSIONS:

Listen to PODCAST

March 17, 2011 The Multiple Sclerosis Emerging Therapies Collaborative Launched
View Article
DATE POSTED T I T L E
September 22, 2010 New Oral Medication for Multiple Sclerosis! Novartis gains FDA approval for Gilenya, a novel first-line MS treatment
PDF: 132 KB
pharrell x adidas nmd adidas nmd human race pharrell x adidas nmd human race black pharrell x adidas nmd human race releasing five colorways pharrell adidas nmd human race red pharrell x adidas nmd human race more new images pharrell x adidas nmd human race green pharrell adidas nmd human race tangerine orange adidas nmd human race pharrell unboxing video pharrell adidas nmd human race tangerine orange pharrell williams pharrell x adidas nmd human race black pharrell adidas nmd human race birthday black adidas nmd human race pharrell x adidas nmd human species black coming soon pharrell x adidas nmd human race light blue pharrell shows yeezy season 4 light blue adidas nmd human race adidas nmd human race light blue adidas nmd human race light blue pharrell x adidas nmd human race fall 2016 colorways more images
adidas yeezy boost 350 v2 turtle dove adidas yeezy boost v2 350 black red release date 2077816816 adidas yeezy boost sply 350 v2 core black copper tan yeezy boost 350 v2 black copper by1605 adidas yeezy boost 350 v2 black copper 2077653185 adidas yeezy boost 350 v2 copper release date adidas yeezy boost 350 black white yeezy boost 350 tan adidas yeezy 350 boost low adidas yeezy 350 boost black adidas yeezy 350 boost legit check real fake adidas yeezy boost 350 beluga 112713 yeezy boost 350 oxford tan adidas yeezy boost 350 v2 black friday adidas yeezy 350 boost 350 v2 black friday adidas yeezy boost 350 v2 adidas yeezy boost 350 v2 grey preview adidas yeezy boost 350 v2 restocked